New Zealand markets close in 5 hours 7 minutes

Clover Health Investments, Corp. (CLOV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6428+0.0128 (+2.03%)
At close: 04:00PM EDT
0.6500 +0.01 (+1.12%)
After hours: 07:36PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.6300
Open0.6350
Bid0.6363 x 1600
Ask0.6420 x 1600
Day's range0.6251 - 0.6550
52-week range0.6060 - 1.6300
Volume2,247,283
Avg. volume9,416,355
Market cap318.374M
Beta (5Y monthly)1.85
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference

    FRANKLIN, Tenn., May 01, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences: CEO, Andrew Toy, and CFO, Peter Kuipers, will participate at the Bank of America 2024 Healthcare Conference on Wednesday, May 15, 2024.CEO, Andrew Toy, will present at

  • GlobeNewswire

    Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

    FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, announced today that effective April 29, 2024, the Talent and Compensation Committee of the Company’s Board of Directors granted a restricted stock unit award (the “RSUs”) to Peter Kuipers, who will be the Company’s new Chief Financial Officer effective a

  • GlobeNewswire

    Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

    FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 7, 2024, to discuss the Company’s business and financial results. First Quarter 2024 Conference Call and Webcast Details: What: Clover Health First Quart